Taxifolin as a novel therapeutic agent for epileptic seizures induced by caffeine-induced oxidative stress in rats
Advances in Clinical and Experimental Medicine · 2023
DOI: 10.17219/acem/172448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2023. Verfasst von Hasan Yasar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine, Erzincan Binali Yıldırım University, Turkey. Hauptthemen laut MEDLINE: Quercetin, Oxidative Stress, Caffeine, Antioxidants. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Faculty of Medicine, Erzincan Binali Yıldırım University, Turkey.
- Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yıldırım University, Turkey.
- Department of Physiology, Faculty of Medicine, Erzincan Binali Yıldırım University, Turkey.
- Department of Molecular Biology, Faculty of Arts and Sciences, Erzincan Binali Yıldırım University, Turkey.
Zitieren
APA
Yasar, H., Altuner, D., Bulut, S., Cicek, B., Gursul, C., Kuzucu, M., & Suleyman, H. (2023). Taxifolin as a novel therapeutic agent for epileptic seizures induced by caffeine-induced oxidative stress in rats. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/172448
Vancouver
Yasar H, Altuner D, Bulut S, Cicek B, Gursul C, Kuzucu M, et al. Taxifolin as a novel therapeutic agent for epileptic seizures induced by caffeine-induced oxidative stress in rats. Advances in Clinical and Experimental Medicine. 2023. doi:10.17219/acem/172448
BibTeX
@article{Yasar2023,
author = {Yasar, Hasan and Altuner, Durdu and Bulut, Seval and Cicek, Betul and Gursul, Cebrail and Kuzucu, Mehmet and Suleyman, Halis},
title = {Taxifolin as a novel therapeutic agent for epileptic seizures induced by caffeine-induced oxidative stress in rats},
journal = {Advances in Clinical and Experimental Medicine},
year = {2023},
doi = {10.17219/acem/172448}
}
EUVIMED